Teglicar

Teglicar

SCHEMBL4450575

CCCCCCCCCCCCCCNC(=O)NC(CC(=O)[O-])C[N+](C)(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CPT2 P23786 3/20 1.00
▸ CPT1A P50416 3/20 1.00
▸ CPT1B Q92523 3/20 1.00
▸ CRAT P43155 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Teglicar SCHEMBL3687135 1.00 CPT2 (1.00) CPT2CPT1ACPT1BCRAT
SCHEMBL2912378 1.00 CPT2 (1.00) CPT2CPT1ACPT1BCRAT
Teglicar SCHEMBL3685373 1.00 CPT2 (1.00) CPT2CPT1ACPT1BCRAT
SCHEMBL2453804 0.93 CPT2 (0.86) CPT2CPT1ACPT1B
SCHEMBL1579627 0.93 CPT2 (0.86) CPT2CPT1ACPT1B
Formic Acid SCHEMBL2454365 0.89 CPT2 (0.78) CPT2CPT1ACPT1B
SCHEMBL6760579 0.88 CPT2 (0.78) CPT2CPT1ACPT1B
Teglicar SCHEMBL13568151 0.87 CPT2 (0.78) CPT2CPT1ACPT1B
SCHEMBL12304907 0.87 CPT2 (0.78) CPT2CPT1ACPT1B
SCHEMBL12304895 0.87 CPT2 (0.78) CPT2CPT1ACPT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090131515-A1 Combination of antidiabetic drugs SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2009-05-21 — — US claimed
EP-1592417-B1 COMBINATION OF ANTIDIABETIC DRUGS SIGMA TAU IND FARMACEUTI (IT) 2007-04-18 — — EP claimed
US-20060058385-A1 Combination of antidiabetic drugs SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2006-03-16 — — US claimed
EP-1592417-A1 COMBINATION OF ANTIDIABETIC DRUGS Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2005-11-09 — — EP claimed
WO-2004069239-A1 COMBINATION OF ANTIDIABETIC DRUGS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2004-08-19 — — WO claimed
US-20250297321-A1 METHOD FOR DETECTING METABOLIC REPROGRAMING OF CANCER TOWARDS FATTY ACIDS METABOLISM INST NAT SANTE RECH MED (FR) 2025-09-25 — — US disclosed
CN-116622514-B Regulation and control method for improving polyunsaturated fatty acid content in microbial thalli and/or microbial grease and application thereof 南京师范大学 2023-10-20 — — CN disclosed
CN-116622514-A Regulation and control method for improving polyunsaturated fatty acid content in microbial thalli and/or microbial grease and application thereof 南京师范大学 2023-08-22 — — CN disclosed
EP-4219764-A1 METHOD FOR DETECTING METABOLIC REPROGRAMING OF CANCER TOWARDS FATTY ACIDS METABOLISM Université Paris Cité (FR) 2023-08-02 — — EP disclosed
US-20190307901-A1 METHOD FOR ENHANCED NUCLEIC ACID TRANSFECTION USING A PEPTIDE ZHANG YUAN (US) 2019-10-10 — — US disclosed
US-20190307703-A1 MULTI-FUNCTIONAL NANOPARTICLES FOR VACCINATION ZHANG YUAN (US) 2019-10-10 — — US disclosed
US-20090131515-A1 Combination of antidiabetic drugs SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2009-05-21 — — US disclosed
EP-1592417-B1 COMBINATION OF ANTIDIABETIC DRUGS SIGMA TAU IND FARMACEUTI (IT) 2007-04-18 — — EP disclosed
US-20060058385-A1 Combination of antidiabetic drugs SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2006-03-16 — — US disclosed
EP-1592417-A1 COMBINATION OF ANTIDIABETIC DRUGS Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2005-11-09 — — EP disclosed
WO-2004069239-A1 COMBINATION OF ANTIDIABETIC DRUGS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2004-08-19 — — WO disclosed
Send feedback